233 related articles for article (PubMed ID: 30207247)
1. Computational Studies in Drug Design Against Cancer.
De B; Bhandari K; Mendonça FJB; Scotti MT; Scotti L
Anticancer Agents Med Chem; 2019; 19(5):587-591. PubMed ID: 30207247
[TBL] [Abstract][Full Text] [Related]
2. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
3. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
Hameed R; Khan A; Khan S; Perveen S
Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
[TBL] [Abstract][Full Text] [Related]
4. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor (EGFR) structure-based bioactive pharmacophore models for identifying next-generation inhibitors against clinically relevant EGFR mutations.
Panicker PS; Melge AR; Biswas L; Keechilat P; Mohan CG
Chem Biol Drug Des; 2017 Oct; 90(4):629-636. PubMed ID: 28303669
[TBL] [Abstract][Full Text] [Related]
6. Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.
Vucicevic J; Nikolic K; Mitchell JBO
Curr Med Chem; 2019; 26(21):3874-3889. PubMed ID: 28707592
[TBL] [Abstract][Full Text] [Related]
7. Discovery and Development of ATP-Competitive mTOR Inhibitors Using Computational Approaches.
Luo Y; Wang L
Curr Pharm Des; 2017 Nov; 23(29):4321-4331. PubMed ID: 28699534
[TBL] [Abstract][Full Text] [Related]
8. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
9. Modern Computational Strategies for Designing Drugs to Curb Human Diseases: A Prospect.
Dar KB; Bhat AH; Amin S; Hamid R; Anees S; Anjum S; Reshi BA; Zargar MA; Masood A; Ganie SA
Curr Top Med Chem; 2018; 18(31):2702-2719. PubMed ID: 30659543
[TBL] [Abstract][Full Text] [Related]
10. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
[TBL] [Abstract][Full Text] [Related]
11. Structure and ligand-based design of P-glycoprotein inhibitors: a historical perspective.
Palmeira A; Sousa E; Vasconcelos MH; Pinto M; Fernandes MX
Curr Pharm Des; 2012; 18(27):4197-214. PubMed ID: 22827485
[TBL] [Abstract][Full Text] [Related]
12. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
[TBL] [Abstract][Full Text] [Related]
13. Recent Trends in Computer-aided Drug Design for Anti-cancer Drug Discovery.
Razia IT; Kanwal A; Riaz HF; Malik A; Ahsan M; Khan MS; Raza A; Sabir S; Sajid Z; Khan MF; Tahir RA; Sehgal SA
Curr Top Med Chem; 2023; 23(30):2844-2862. PubMed ID: 38031798
[TBL] [Abstract][Full Text] [Related]
14. Abelson tyrosine-protein kinase 1 as principal target for drug discovery against leukemias. Role of the current computer-aided drug design methodologies.
Speck-Planche A; Luan F; Cordeiro MN
Curr Top Med Chem; 2012; 12(24):2745-62. PubMed ID: 23368101
[TBL] [Abstract][Full Text] [Related]
15. Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.
Guedes RA; Serra P; Salvador JA; Guedes RC
Molecules; 2016 Jul; 21(7):. PubMed ID: 27438821
[TBL] [Abstract][Full Text] [Related]
16. Finding Novel Anti-carcinomas Compounds by Targeting SFRP4 Through Molecular Modeling, Docking and Dynamic Simulation Studies.
Hassan M; Azhar M; Abbas Q; Raza H; Moustafa AA; Shahzadi S; Ashraf Z; Seo SY
Curr Comput Aided Drug Des; 2018; 14(2):160-173. PubMed ID: 29332600
[TBL] [Abstract][Full Text] [Related]
17. Recent advances on CDK inhibitors: An insight by means of in silico methods.
Tutone M; Almerico AM
Eur J Med Chem; 2017 Dec; 142():300-315. PubMed ID: 28802482
[TBL] [Abstract][Full Text] [Related]
18. Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.
Hasan MR; Alsaiari AA; Fakhurji BZ; Molla MHR; Asseri AH; Sumon MAA; Park MN; Ahammad F; Kim B
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807415
[TBL] [Abstract][Full Text] [Related]
19. Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.
Abdolmaleki A; Ghasemi JB; Ghasemi F
Curr Drug Targets; 2017; 18(5):556-575. PubMed ID: 26721410
[TBL] [Abstract][Full Text] [Related]
20. Application of
Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]